Your browser doesn't support javascript.
loading
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial.
Annala, M; Fu, S; Bacon, J V W; Sipola, J; Iqbal, N; Ferrario, C; Ong, M; Wadhwa, D; Hotte, S J; Lo, G; Tran, B; Wood, L A; Gingerich, J R; North, S A; Pezaro, C J; Ruether, J D; Sridhar, S S; Kallio, H M L; Khalaf, D J; Wong, A; Beja, K; Schönlau, E; Taavitsainen, S; Nykter, M; Vandekerkhove, G; Azad, A A; Wyatt, A W; Chi, K N.
Afiliación
  • Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Fu S; Department of Medical Oncology, BC Cancer, Vancouver, Canada; Oncology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Sipola J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Iqbal N; Medical Oncology, Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Canada.
  • Ferrario C; Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Ong M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada.
  • Wadhwa D; BC Cancer - Kelowna Centre, Kelowna, Canada.
  • Hotte SJ; Oncology, Juravinski Cancer Centre, Hamilton, Canada.
  • Lo G; Department of Medical Oncology, R. S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Canada.
  • Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Wood LA; QEII Health Sciences Centre, Halifax, Canada.
  • Gingerich JR; Department of Medical Oncology and Hematology, Cancer Care Manitoba, Winnipeg, Canada.
  • North SA; Department of Oncology, University of Alberta, Edmonton, Canada.
  • Pezaro CJ; Eastern Health Clinical School, Monash University, Australia; Department of Oncology, Eastern Health, Australia.
  • Ruether JD; Tom Baker Cancer Centre, Calgary, Canada.
  • Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Kallio HML; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Khalaf DJ; Department of Medical Oncology, BC Cancer, Vancouver, Canada.
  • Wong A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Beja K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Schönlau E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada. Electronic address: awwyatt@mail.ubc.ca.
  • Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, BC Cancer, Vancouver, Canada. Electronic address: kchi@bccancer.bc.ca.
Ann Oncol ; 32(7): 896-905, 2021 07.
Article en En | MEDLINE | ID: mdl-33836265
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Finlandia